Manufacturer record
Vance & Health Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Vance & Health Pharmaceuticals Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between June 2023 and July 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: RD09- 2202, ALBENDAZOLE TABLETS I.P. 400 mg (FOZY) (exp Sep 2024). CDTL Hyderabad (CDSCO lab) found it not of standard quality: Test for Dissolution. Listed in the July 2023 alert.
Records by type
2 records linked to Vance & Health Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| ALBENDAZOLE TABLETS I.P. 400 mg (FOZY) | Batch RD09- 2202Mfg Oct 2022 · Exp Sep 2024 | Test for DissolutionDissolution | CDTL HyderabadCDSCO lab | Jul 2023 |
| ALBENDAZOLE TABLETS I.P. 400 MG (FOZY) | Batch RD09-2202Mfg Oct 2022 · Exp Sep 2024 | Test for DissolutionDissolution | CDTL HyderabadCDSCO lab | Jun 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.